Exatecan Intermediate 2 (hydrochloride)
Exatecan Intermediate 2 hydrochloride (Compound B) is an intermediate of Exatecan (DX-8951, HY-13631) . Exatecan is an anticancer agent belonging to the class of camptothecin analogs. Exatecan interferes with the proliferation and division of tumor cells by interacting with DNA, thereby inhibiting tumor growth. Exatecan is primarily used for research of a variety of cancers including ovarian, lung and breast cancers[1].
Product Specifications
CAS Number
[2437603-23-9]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ADC Payload; Drug Intermediate
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/exatecan-intermediate-2-hydrochloride.html
Concentration
10mM
Purity
99.94
Solubility
DMSO : 12.5 mg/mL (ultrasonic)
Smiles
CC(NC(CCC1=C2C(N)=CC(F)=C1C)C2=O)=O.Cl
Molecular Formula
C13H16ClFN2O2
Molecular Weight
286.73
Precautions
H302, H315, H319, H335
References & Citations
[1]Lv Xianyu, et al. Preparation of camptothecin derivative intermediate. China, CN115197088. 2022-10-18.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Camptothecins
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LARS2 (KIAA0028, Probable Leucine-tRNA Ligase, Mitochondrial, Leucyl-tRNA Synthetase) (MaxLight 650)
Lentiviral human UGT8 shRNA (UAS) - Lentiviral human UGT8 shRNA (UAS, GFP) (100)
